Product Recalls in Montana

Product recalls affecting Montana — including food, drugs, consumer products, medical devices, and vehicles distributed to Montana. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,548 recalls have been distributed to Montana in the last 12 months.

48,326 total recalls
2,548 in last 12 months

Showing 50415060 of 13,407 recalls

DrugOctober 23, 2019· Perrigo Company PLC

Recalled Item: Maximum Strength Acid Reducer Recalled by Perrigo Company PLC Due to CGMP...

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 23, 2019· Perrigo Company PLC

Recalled Item: Regular Strength Acid Reducer Recalled by Perrigo Company PLC Due to CGMP...

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 23, 2019· Mylan Pharmaceuticals Inc.

Recalled Item: Alprazolam Tablets Recalled by Mylan Pharmaceuticals Inc. Due to Presence of...

The Issue: Presence of Foreign Substance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 23, 2019· Perrigo Company PLC

Recalled Item: Maximum Strength Acid Reducer Recalled by Perrigo Company PLC Due to CGMP...

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 23, 2019· Perrigo Company PLC

Recalled Item: Regular Strength Acid Reducer Recalled by Perrigo Company PLC Due to CGMP...

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 23, 2019· Perrigo Company PLC

Recalled Item: Regular Strength Acid Reducer Recalled by Perrigo Company PLC Due to CGMP...

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 23, 2019· Perrigo Company PLC

Recalled Item: Maximum Strength Acid Reducer Recalled by Perrigo Company PLC Due to CGMP...

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 23, 2019· Perrigo Company PLC

Recalled Item: Maximum Strength Acid Reducer Recalled by Perrigo Company PLC Due to CGMP...

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 23, 2019· Perrigo Company PLC

Recalled Item: Maximum Strength Acid Reducer Recalled by Perrigo Company PLC Due to CGMP...

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 23, 2019· Perrigo Company PLC

Recalled Item: Maximum Strength Acid Reducer Recalled by Perrigo Company PLC Due to CGMP...

The Issue: CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Maximum Strength Zantac 150 mg Distributed by: Chattem Recalled by...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Cool Mint Maximum Strength Zantac 150 mg Recalled by Sanofi-Aventis U.S. LLC...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Regular Strength Zantac 150 mg Distributed by: Chattem Recalled by...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Regular Strength Zantac 75 mg Recalled by Sanofi-Aventis U.S. LLC Due to...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Zantac 150 mg Recalled by Sanofi-Aventis U.S. LLC Due to CGMP Deviations:...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Zantac 75 mg Recalled by Sanofi-Aventis U.S. LLC Due to CGMP Deviations:...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Regular Strength Zantac 150 mg Recalled by Sanofi-Aventis U.S. LLC Due to...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Regular Strength Zantac 75 mg Recalled by Sanofi-Aventis U.S. LLC Due to...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Regular Strength Zantac 75 mg Recalled by Sanofi-Aventis U.S. LLC Due to...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Regular Strength Zantac 75 mg Recalled by Sanofi-Aventis U.S. LLC Due to...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund